Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 09:00 ET | Source: Wandercraft

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss

Wandercraft earns second FDA clearance for expanded indications of Atalante X, enabling rehab for spinal cord injury and multiple sclerosis patients.
October 31, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
October 30, 2025 16:05 ET | Source: BioStem Technologies, Inc.

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
October 30, 2025 08:00 ET | Source: ORGANOX LIMITED

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

$1.5 billion OrganOx acquisition by Terumo strengthens global leadership in organ technology and accelerates progress toward making every organ count
October 28, 2025 16:30 ET | Source: SS Innovations

SS Innovations Reports Third Quarter 2025 Financial Results

SS Innovations Reports Third Quarter 2025 Financial Results
October 28, 2025 12:45 ET | Source: ONWARD Medical NV

ONWARD Medical Publishes Closing of Bookbuild Offering

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
October 28, 2025 07:00 ET | Source: GHO Capital

GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare

Fund IV brings total Assets Under Management (AUM) to c. €9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe GHO has diversified its investor base...
October 28, 2025 04:00 ET | Source: GHO Capital

GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare

Fund IV brings total Assets Under Management (AUM) to c. €9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe GHO has diversified its investor base...
October 27, 2025 16:15 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
October 27, 2025 07:00 ET | Source: EDAP TMS S.A.

EDAP to Participate in the UBS Global Healthcare Conference

EDAP to Participate in the UBS Global Healthcare Conference Company to Host 1x1 Investor Meetings on Monday, November 10th, 2025 AUSTIN, Texas, October 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the...